The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews

It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.

<img src='https://npr.brightspotcdn.com/dims3/default/strip/false/crop/6000x4000+0+0/resize/6000x4000!/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F1e%2Fed%2F236f2ee9474b90de9aa208f75b3c%2F2026-04-28t000000z-1942889809-mt1imgosp000gcboe2-rtrmadp-3-imago-images-sports.JPG' alt='An injection of the new drug lenacapavir provides six months of protection against infection by HIV.'/><p>It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.</p><p>(Image credit: Osodi Emmanuel)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=g-s1-137742' />